DAFTAR PUSTAKA Adiwijaya, J.A., 2011. 'Efek dan Resistansi Clopidogrel pada Sindrom Koroner Akut'. Medika Jurnal Kedokteran Indonesia, XXXVII: . Antithrombotic Trialists’ Collaboration, 2002. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ (Clinical research ed.), 324: 71–86. Bhatt, D.L., Fox, K.A.A., Hacke, W., Berger, P.B., Black, H.R., Boden, W.E., dkk., 2006. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. The New England journal of medicine, 354: 1706–1717. CAPRIE Steering Committee, 1996. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet, 348: 1329–1339. Clark, M.A., Finkel, R., Rey, J.A., dan Whalen, K., 2012. Pharmacology, 5th ed. Lippincont Williams & Wilkins, Philadelphia. Dahlan, M.S., 2013. Besar Sampel Dan Cara Pengambilan Sampel: Dalam Penelitian Kedokteran Dan Kesehatan, 3rd ed. Salemba Medika, Jakarta. Dewonto, H.R., 2009. Antikoagulan, Antitrombotik, trombolitik dan Hemostatik, dalam: Gunawan, G.S., Nafrialdi, S.R., Elysabeth (Eds.), Farmakologi Dan Terapi. Departemen Farmakologi dan Terapeutik Fakultas Kedokteran Universitas Indonesia, Jakarta, hal. 804–819. Diener, H.-C., Bogousslavsky, J., Brass, L.M., Cimminiello, C., Csiba, L., Kaste, M., dkk., 2004. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet, 364: 331–337. Diener, H.C., Cunha, L., Forbes, C., Sivenius, J., Smets, P., dan Lowenthal, A., 1996. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. Journal of the neurological sciences, 143: 1–13. Eikelboom, J.W., Emery, J., dan Hankey, G.J., 2010. The use of platelet function assays may help to determine appropriate antiplatelet treatment options in a patient with recurrent stroke on baby aspirin: against. Stroke; a journal of cerebral circulation, 41: 2398–2399.
51
Fagan, S.C. dan Hess, D.C., 2008. Stroke, dalam: Dipiro, J.T., Talbert, R.L., Yee, G.C., Matzke, G.R., Wells, B.G., Posey, L.M. (Eds.), Pharmacotherapy A Pathophysiologic Approach. The McGraw Companies, United States of America, hal. 379–380. Farrell, B., Godwin, J., Richards, S., dan Warlow, C., 1991. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. Journal of neurology, neurosurgery, and psychiatry, 54: 1044–1054. Favilla, C.G., Mullen, M.T., Ali, M., Higgins, P., dan Kasner, S.E., 2011. Sulfonylurea Use Before Stroke Does Not Influence Outcome. Stroke, 42: 710–715. Furie, K.L., Kasner, S.E., Adams, R.J., Albers, G.W., Bush, R.L., Fagan, S.C., dkk., 2011. Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke, 42: 227–276. Gofir, A., 2009. Manajemen Stroke Evidence Based Medicine. Pustaka Cendekia Press, Yogyakarta. Goldstein, L.B., Adams, R., Alberts, M.J., Appel, L.J., Brass, L.M., Bushnell, C.D., dkk., 2006. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation, 113: e873–923. Gouya, G., Arrich, J., Wolzt, M., Huber, K., Verheugt, F.W.A., Gurbel, P.A., dkk., 2014. Antiplatelet Treatment for Prevention of Cerebrovascular Events in Patients With Vascular Diseases A Systematic Review and Meta-Analysis. Stroke, 45: 492–503. Hankey, G.J., Jamrozik, K., Broadhurst, R.J., Forbes, S., Burvill, P.W., Anderson, C.S., dkk., 1998. Long-term risk of first recurrent stroke in the Perth Community Stroke Study. Stroke; a journal of cerebral circulation, 29: 2491–2500. Hartwig, M.J., 2006. Penyakit Serebrovaskular, dalam: Hartono, H., Susi, N., Wulansari, P., Mahadani (Eds.), Patofisiologi Konsep Klinis ProsesProses Penyakit. Penerbit Buku Kedokteran EGC, Jakarta.
52
He, J., Whelton, P., Vu, B., dan Klag, M.J., 1998. Aspirin and Risk of Hemorrhagic Stroke: A Meta-Analysis of Randomized Controlled Trials. JAMA : the journal of the American Medical Association, 280: 1930–1935. Ikawati, Z., 2011. Farmakoterapi Penyakit Sistem Saraf Pusat. Buesa Ilmu, Yogyakarta. Katzung, B.G., 2003. Drugs Used in Disorders of Coagulation, In Basic & Clinical Pharmacology, 9th ed. The McGraw Companies, United States of America. Kernan, W.N., Ovbiagele, B., Black, H.R., Bravata, D.M., Chimowitz, M.I., Ezekowitz, M.D., dkk., 2014. Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke, STR.0000000000000024. Kirtania, K., Sultana, N., Ahmed, S., dan Khatun, A., 2010. Association of Hypertension and Smoking with Ischaemic Stroke. Bangladesh Journal of Medical Biochemistry, 3: . Kirtania, K., Sultana, N., Hossain, M., Ahmed, S., dan Khatun, A., 2011. Association of Diabetes Mellitus and Smoking with Ischaemic Stroke. Journal of Dhaka Medical College, 20: . Kowalak, J.., Welsh, W., dan Mayer, B., 2012. Buku Ajar Patofisiologi. Buku Kedokteran EGC, Jakarta. Lacy, C.F., Armstrong, L.., Goldman, M.., dan Lance, L.., 2008. Drug Information Handbook A Comprehensive Resource for All Clinicians and Healthcare Professionals, 17th ed. Lexi-Comps Drus Reference Handbook, United States of America. Laksmawati, 1999. 'Faktor Yang Mempengaruhi Stroke Non Hemoragik Ulang ( Studi kasus kontrol di Bangsal Bagian Saraf RSUP Dr. Kariadi )', Tesis, Program Pendidikan Pasca sarjana Universitas Diponegoro. Mansjoer, A., 2000. Kapita Selekta Kedokteran, 3rd ed, 1. Media Aesculapis Fakultas Kedokteran Universitas Indonesia, Jakarta. McCann, A., 2007. Antiplatelet Therapy After Coronary Occlusion. Australian Prescriber, 92–96. Mega, J.L., Close, S.L., Wiviott, S.D., Shen, L., Hockett, R.D., Brandt, J.T., dkk., 2009. Cytochrome p-450 polymorphisms and response to clopidogrel. The New England journal of medicine, 360: 354–362. National Stroke Association, 2010. HOPE: A Stroke Recovery Guide. Stroke, . 53
Nufus, H., 2012. 'Peran Sitikolin untuk Tata Laksana Stroke Iskemik Akut'. Medika Jurnal Kedokteran Indonesia, XXXVIII: . Nugroho, A.E., 2011. Farmakologi Obat-Obat Penting Dalam Pembelajaran Ilmu Farmasi Dan Dunia Kesehatan. Pustaka Pelajar, Yogyakarta. Price, S.A. dan Lorraine, M.W., 2005. Pathophysiology: Clinical Concepts of Disease Processes, 6th ed. Mosby, MichigaN. Purnama, S.D., Pambudi, P., dan Audhah, N.A., 2013. Perbandingan Efektivitas Asetosal Dan Kombinasi Asetosal-Klopidogrel Terhadap Pasien Stroke Iskemik Akut. Jurnal Berkala Kedokteran, 9: 109–118. Sacco, R.L., Adams, R., Albers, G., Alberts, M.J., Benavente, O., Furie, K., dkk., 2006. Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline. Stroke, 37: 577–617. Sacco, R.L., Kasner, S.E., Broderick, J.P., Caplan, L.R., Connors, J.J. (Buddy), Culebras, A., dkk., 2013. An Updated Definition of Stroke for the 21st Century A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke, 44: 2064–2089. Sari, A.W., 2009. 'Faktor-faktor Resiko Stroke di Indonesia'. Badan Penelitian dan Pengembangan Kesehatan, . Seifert, C.L., Poppert, H., Sander, D., Feurer, R., Etgen, T., Ander, K.-H., dkk., 2012. Depressive Symptoms and the Risk of Ischemic Stroke in the Elderly—Influence of Age and Sex. PLoS ONE, 7: e50803. Selim, M.H. dan Molina, C.A., 2010. Platelet Function Assays in Stroke Management More Study Is Needed. Stroke, 41: 2396–2397. Shuldiner, A.R., O’Connell, J.R., Bliden, K.P., Gandhi, A., Ryan, K., Horenstein, R.B., dkk., 2009. Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy. JAMA: the journal of the American Medical Association, 302: 849–857. Shulga, O., 2011. Antiplatelets in secondary stroke prevention. Frontiers in Stroke, 2: 36. Silva, G.S., Farrell, S., Shandra, E., Viswanathan, A., dan Schwamm, L.H., 2012. The status of telestroke in the United States: a survey of currently active stroke telemedicine programs. Stroke; a Journal of Cerebral Circulation, 43: 2078–2085. 54
Siswanto, Y., 2005. 'Beberapa Faktor Risiko yang Mempengaruhi Kejadian Stroke Berulang: Studi Kasus di RS. Dr. Kariadi Semarang', Tesis, Universitas Diponegoro, Semarang. Susanti, M.E., 2014. 'Evaluasi Penggunaan Obat Antiplatelet Terhadap Kejadian Pendarahan Saluran Cerna Beserta Faktor Resikonya Pada Pasien Stroke Iskemik di Rumah Sakit Bethesda Yogyakarta', Tesis, UGM. SPS3 Investigators, Benavente, O.R., Hart, R.G., McClure, L.A., Szychowski, J.M., Coffey, C.S., dkk., 2012. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. The New England Journal of Medicine, 367: 817–825. The Dutch TIA Trial Study Group, 1991. A Comparison of Two Doses of Aspirin (30 mg vs. 283 mg a Day) in Patients after a Transient Ischemic Attack or Minor Ischemic Stroke. New England Journal of Medicine, 325: 1261– 1266. Wang, Y., Wang, Y., Zhao, X., Liu, L., Wang, D., Wang, C., dkk., 2013. Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack. New England Journal of Medicine, 369: 11–19. World Health Organization, 2006. The WHO STEPwise Approach to Stroke Surveillance.
55
